Affordability Check
How to afford BYFAVO
Generic name: remimazolam besylate
Pick how you're covered. We'll show you the cheapest legitimate way to get BYFAVO — your insurance copay, manufacturer savings, charity grants, or cash price. It takes 30 seconds and we never ask for your personal information.
Pick an option above to see your specific path.
Different insurance means different laws and different savings. For example, Medicare patients cannot use manufacturer copay cards (federal law) — but the manufacturer almost always has a Patient Assistance Program that gives the drug free.
About BYFAVO and its cost
What is this medication? BYFAVO is a prescription medicine containing the drug remimazolam, which belongs to a class of medications known as benzodiazepines. It is primarily used in adults for the induction and maintenance of procedural sedation. This means it is administered to help patients feel relaxed, calm, and sleepy during short medical procedures or diagnostic tests that typically last thirty minutes or less. Common examples of such procedures include colonoscopies, bronchoscopies, or other minor surgeries where full general anesthesia is not necessary.
The medication is administered intravenously by a healthcare professional in a clinical environment where the patient can be monitored. It works by targeting specific receptors in the brain to produce a sedative effect, allowing the medical procedure to be performed more comfortably. One of the primary benefits of this medication is its rapid onset of action and its ability to allow for a relatively quick recovery time once the procedure is finished. Medical staff will observe the patient during and after the injection to ensure they wake up safely and respond well to the sedation.
BYFAVO is made by Eagle. Like most brand-name drugs, it's priced at a high list price — but patients rarely pay that list price. The options above are the real paths most people use to get it affordably.
Common questions
What's the cheapest way to afford BYFAVO?
It depends on your insurance. On Medicare, apply for the manufacturer's Patient Assistance Program (PAP) — it gives the drug free if you meet income requirements. With private insurance, the manufacturer copay card usually drops your copay to $0-$25. Uninsured patients should compare the PAP with Cost Plus Drugs cash price.
Can I use a copay card with Medicare for BYFAVO?
No — federal law (the Anti-Kickback Statute) prohibits manufacturer copay cards on Medicare, Medicaid, TriCare, and VA prescriptions. But Eagle has a separate Patient Assistance Program for Medicare beneficiaries. Check the options above.
Does my Medicare Part D plan cover BYFAVO?
Part D coverage varies by plan. We query the CMS Prescription Drug Plan file to show you what percentage of plans cover it and at what tier. For your exact copay, pick "Medicare" above and check your plan's Summary of Benefits, or log in to Medicare.gov.
How long does a Patient Assistance Program take?
Most PAPs take 2-6 weeks from application to first fill. Ask the manufacturer about a "bridge supply" — many will ship 30 days free while your application is being reviewed so you don't go without the drug.
What if I have a high-deductible plan?
For generics, Cost Plus Drugs cash price is often cheaper than your deductible-phase copay. For brand names, the manufacturer copay card almost always wins. A GoodRx coupon can be a last resort for uncovered drugs, but it doesn't count toward your deductible.
Are there charity grants for Aftercare?
Charities like HealthWell Foundation, PAN Foundation, Good Days, and the National Organization for Rare Disorders provide copay help for specific conditions. Funds often run out mid-year — apply early. We list the specific grants for your condition in the options above.
More about BYFAVO
Full BYFAVO drug page
FDA label, prior authorization rules, full indications list
More options for Aftercare
Drugs, grants, and assistance for this condition
Guide to Patient Assistance Programs
How PAPs work, who qualifies, typical wait times
If your insurance denied coverage
5-level appeal playbook — Medicare has a 60% win rate at Level 3